HumanaMedicare Advantage · Coverage · Medicare Advantage · Cardiology, Genetics, Family Medicine +1 moreMedium impact
Genetic Testing for Hereditary Cardiovascular Disease - Medicare Advantage (Revised)
Effective date
Sep 2, 2025
Identified
Jun 24, 2026
Summary
Humana Medicare Advantage has revised their genetic testing policy for hereditary cardiovascular disease, effective September 2, 2025. The policy establishes coverage determination criteria for genetic testing related to inherited cardiomyopathies, channelopathies, familial hypercholesterolemia, and Marfan syndrome, requiring compliance with CMS guidelines and applicable Local Coverage Determinations.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
01Before September 2, 2025: Billing team must review and update genetic testing procedures for cardiovascular conditions to ensure compliance with Humana Medicare Advantage requirements.
02Verify that genetic testing orders meet CMS analytical and clinical validity standards per applicable Local Coverage Determinations.
03Update prior authorization workflows to reference the new policy number HUM-1102-006 for genetic testing related to cardiomyopathies, channelopathies, familial hypercholesterolemia, and Marfan syndrome.
Original notice
Genetic Testing for Hereditary Cardiovascular Disease - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.